Kristopher Kaufman
Family Medicine · Bolivar, MONPI 1023029998
Payments from drug & device makers
Across 132 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$477
- AbbVie$305
- Pfizer$290
- Novo Nordisk$239
- Amgen$208
- GSK$147
- plus $576 from 14 others
What the payments were for
- Food & beverage$2,242100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 23 | $477 |
| AbbVie | 13 | $305 |
| Pfizer | 22 | $290 |
| Novo Nordisk | 15 | $239 |
| Amgen | 12 | $208 |
| GSK | 10 | $147 |
| AstraZeneca | 8 | $121 |
| Lilly USA, LLC | 6 | $100 |
| Dexcom, Inc. | 4 | $65 |
| Merck | 4 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $41 |
| Exact Sciences | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $35 |
| Organon | 2 | $23 |
| Novartis | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Bayer | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
How this compares
$2,242 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 94 | $102,006 |
| EliquisApixaban | 74 | $64,968 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 86 | $63,947 |
| XareltoRivaroxaban | 67 | $58,169 |
| JanuviaSitagliptin Phosphate | 60 | $49,712 |
| TrulicityDulaglutide | 46 | $45,110 |
| FarxigaDapagliflozin Propanediol | 32 | $27,553 |
| MyrbetriqMirabegron | 22 | $23,218 |
| LinzessLinaclotide | 38 | $23,167 |
| MounjaroTirzepatide | 21 | $22,722 |
| Breo ElliptaFluticasone/Vilanterol | 43 | $19,839 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 40 | $18,837 |
| Spiriva RespimatTiotropium Bromide | 33 | $17,418 |
| Repatha SureclickEvolocumab | 19 | $14,989 |
| Spiriva HandihalerTiotropium Bromide | 17 | $14,067 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arexvy | $147 | $116,030211 claims |
| Novo NordiskOzempic | $239 | $102,00694 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $100 | $67,83267 claims |
| PfizerEliquis | $290 | $64,96874 claims |
| MerckJanuvia, Janumet | $62 | $57,01373 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $121 | $35,77545 claims |
| Boehringer IngelheimSpiriva Respimat, Combivent Respimat | $12 | $23,50445 claims |
| AbbVieLinzess | $305 | $23,16738 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Bolivar
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.